A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea

NCT04470830 · clinicaltrials.gov ↗
COMPLETED
Status
718
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Celltrion Pharm, Inc.